Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
134.68
+0.31 (0.23%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Cardinal Health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 137.93, with a low estimate of 120 and a high estimate of 155. The average target predicts an increase of 2.42% from the current stock price of 134.68.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 5 | 6 | 5 | 5 | 5 | 5 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $150 → $155 | Strong Buy | Maintains | $150 → $155 | +15.09% | Apr 11, 2025 |
| Mizuho | Mizuho | Buy Maintains $142 → $150 | Buy | Maintains | $142 → $150 | +11.38% | Mar 31, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $140 → $150 | Hold → Strong Buy | Upgrades | $140 → $150 | +11.38% | Feb 5, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $142 → $145 | Hold | Maintains | $142 → $145 | +7.67% | Feb 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $135 → $136 | Hold | Maintains | $135 → $136 | +0.98% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
225.35B
from 226.83B
Decreased by -0.65%
Revenue Next Year
245.05B
from 225.35B
Increased by 8.74%
EPS This Year
8.03
from 3.45
Increased by 132.88%
EPS Next Year
9.05
from 8.03
Increased by 12.68%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 236.1B | 264.6B | 285.6B | ||
| Avg | 225.3B | 245.0B | 263.2B | ||
| Low | 215.5B | 233.5B | 246.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1% | 17.4% | 16.6% | ||
| Avg | -0.7% | 8.7% | 7.4% | ||
| Low | -5.0% | 3.6% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.44 | 9.63 | 10.83 | ||
| Avg | 8.03 | 9.05 | 10.00 | ||
| Low | 7.75 | 8.57 | 9.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 144.7% | 19.8% | 19.6% | ||
| Avg | 132.9% | 12.7% | 10.5% | ||
| Low | 124.7% | 6.6% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.